MedPAC Report Explores Ways For CMS To Use Cost-Effectiveness Analysis
This article was originally published in The Gray Sheet
Executive Summary
CMS could select certain expensive medical devices, surgical and diagnostic procedures for government-sponsored cost-effectiveness research, according to MedPAC's June report to Congress
You may also be interested in...
Cost-Effectiveness Studies Too Diverse To Inform CMS Policy, Report Finds
A report finds that the methodologies used in published cost-effectiveness studies are too diverse to inform Medicare policy-making, but that the literature could be useful in singling out therapies for a closer look
Cost-Effectiveness Studies Too Diverse To Inform CMS Policy, Report Finds
A report finds that the methodologies used in published cost-effectiveness studies are too diverse to inform Medicare policy-making, but that the literature could be useful in singling out therapies for a closer look
Cost-Benefit Decisions Will Reside With Docs/Patients, Not CMS – McClellan
CMS will continue to refrain from incorporating cost-effectiveness analyses into coverage decisions, Administrator Mark McClellan affirmed May 18